{"schema_version":"secwatch.filing_event.v1","accession":"0001093557-25-000278","form_type":"8-K","ticker":"DXCM","cik":"0001093557","company_name":"DEXCOM INC","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.773594+00:00","generated_at":"2026-05-17T01:13:50.039544+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Dexcom Q3 revenue $1.209B (+22% YoY); raises FY 2025 revenue guidance to $4.63-4.65B","bullets":["GAAP EPS $0.70 vs $0.34 YoY; non-GAAP EPS $0.61 vs $0.45 YoY.","U.S. revenue +21% YoY; international revenue +22% reported, +18% organic.","GAAP operating margin 20.1% (480 bps improvement); non-GAAP operating margin 22.6%.","Stelo surpassed $100M revenue in first 12 months; submitted Dexcom Smart Basal to FDA.","Cash and marketable securities $3.32B; revolver undrawn."],"urls":{"canonical":"https://secwatch.observer/filing/0001093557-25-000278","json":"https://secwatch.observer/filing/0001093557-25-000278.json","markdown":"https://secwatch.observer/filing/0001093557-25-000278.md","text":"https://secwatch.observer/filing/0001093557-25-000278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/0001093557-25-000278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/dxcm-20251030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:13:50.039544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}